ABSTRACT
BACKGROUND: Surgical site infection (SSI) is a common complication of hysterectomy. Minimally invasive hysterectomy has lower infection rates than abdominal hysterectomy. The lower SSI rates reflect the role and benefit in infection control of having minimal incisions, rather than a large anterior abdominal wall incision. Despite the lower rates, SSI after laparoscopic hysterectomy is not uncommon.In this article, we review pre-, intra-, and postoperative risk factors for infection. Rates of postoperative fever after laparoscopic hysterectomy and when evaluation for infection is warranted in a febrile patient are also reviewed. DATABASE: PubMed was searched for English-only articles using National Library of Medicine Medical Subject Headings(MESH) terms and keywords including but not limited to "postoperative," "surgical site," "infection," "fever," "laparoscopic," "laparoscopy," and "hysterectomy." CONCLUSIONS: Reducing hospital-acquired infections such as SSI is one of the more effective ways of improving patient safety. Knowledge and understanding of risk factors for infection following laparoscopic hysterectomy enable the gynecologic surgeon or hospital to implement targeted preventive measures.
Subject(s)
Hysterectomy/adverse effects , Laparoscopy/adverse effects , Surgical Wound Infection/prevention & control , Female , Humans , Hysterectomy/methods , Incidence , Risk Factors , Surgical Wound Infection/epidemiology , United States/epidemiologyABSTRACT
The development of surgical site infection (SSI) remains the most common complication of gynecologic surgical procedures and results in significant patient morbidity. Gynecologic procedures pose a unique challenge in that potential pathogenic microorganisms from the skin or vagina and endocervix may migrate to operative sites and can result in vaginal cuff cellulitis, pelvic cellulitis, and pelvic abscesses. Multiple host and surgical risk factors have been identified as risks that increase infectious sequelae after pelvic surgery. This paper will review these risk factors as many are modifiable and care should be taken to address such factors in order to decrease the chance of infection. We will also review the definitions, microbiology, pathogenesis, diagnosis, and management of pelvic SSIs after gynecologic surgery.
Subject(s)
Gynecologic Surgical Procedures/adverse effects , Pelvic Infection , Postoperative Complications , Surgical Wound Infection , Abscess/drug therapy , Abscess/microbiology , Cellulitis/drug therapy , Cellulitis/microbiology , Female , Host-Pathogen Interactions , Humans , Parametritis/drug therapy , Parametritis/microbiology , Pelvic Infection/drug therapy , Pelvic Infection/microbiology , Postoperative Complications/microbiology , Risk Factors , Surgical Wound Infection/drug therapy , Surgical Wound Infection/microbiology , Vagina/microbiology , Vaginitis/drug therapy , Vaginitis/microbiologyABSTRACT
Immunization is the most effective measure available to prevent influenza and its complications, and health care workers (HCWs) play a pivotal role. We conducted a cross-sectional survey study to determine HCWs knowledge and opinions regarding influenza vaccine and its acceptance at our institution. The most important reason for vaccine uptake was because it required formal declination (33%); physicians were more likely to be vaccinated because of patient care, whereas nurses were more likely to be vaccinated because it required formal declination.
Subject(s)
Attitude of Health Personnel , Health Knowledge, Attitudes, Practice , Health Personnel , Influenza Vaccines/immunology , Influenza, Human/prevention & control , Vaccination/statistics & numerical data , Cross-Sectional Studies , Humans , Influenza Vaccines/administration & dosage , United StatesABSTRACT
Postoperative infection is the most commonly seen complication of surgery in obstetrics and gynecology. The use of antibiotic prophylaxis has greatly decreased though not completely eliminated this adverse outcome. Postoperative infections include wound cellulitis, wound abscess, endomyometritis, pelvic cellulitis, and pelvic abscess. Infections usually manifest as fever and greater than normal postoperative pain. Refractory fevers maybe because of septic pelvic vein thrombophlebitis or maybe noninfectious in origin. Broad-spectrum antibiotics should be initiated as soon as possible when diagnosis of postoperative infection is made; most patients will respond to treatment within 24 to 48 hours when appropriate antibiotics are selected.
Subject(s)
Cesarean Section/adverse effects , Endometritis/drug therapy , Hysterectomy/adverse effects , Surgical Wound Infection/drug therapy , Surgical Wound Infection/etiology , Anti-Bacterial Agents/therapeutic use , Endometritis/diagnosis , Endometritis/etiology , Female , Humans , Pelvic Infection/therapy , Pelvis/blood supply , Risk Factors , Surgical Wound Infection/diagnosis , Thrombophlebitis/diagnosis , Thrombophlebitis/drug therapy , Thrombophlebitis/microbiology , Urinary Tract Infections/drug therapyABSTRACT
Herpes simplex virus (HSV) infections are highly prevalent and may have devastating consequences if transmitted to newborns. The highest risk of transmission is when the mother has primary HSV infection (rather than recurrence of chronic infection) late in pregnancy. Clinicians should obtain a careful history, performing serologic testing and counseling as appropriate. Delayed diagnosis of neonatal HSV is associated with high mortality. Even with adequate treatment, permanent sequelae, such as cerebral palsy and developmental delay, may occur. Clinicians should develop prudent strategies to avoid primary HSV acquisition during pregnancy, and provide prophylaxis or treatment when indicated.
Subject(s)
Herpes Simplex/prevention & control , Infectious Disease Transmission, Vertical/prevention & control , Pregnancy Complications, Infectious/therapy , Antiviral Agents/therapeutic use , Breast Feeding , Female , Fetal Membranes, Premature Rupture , Herpes Genitalis/diagnosis , Herpes Genitalis/transmission , Herpes Simplex/drug therapy , Herpes Simplex/transmission , Humans , Infant, Newborn , Pregnancy , Premature Birth/prevention & control , SimplexvirusABSTRACT
The diagnosis of acute pelvic inflammatory disease (PID) is usually based on clinical criteria and can be challenging for even the most astute clinicians. Although diagnostic accuracy is advocated, antibiotic treatment should be instituted if there is a diagnosis of cervicitis or suspicion of acute PID. Currently, no single test or combination of diagnostic indicators have been found to reliably predict PID, and laparoscopy cannot be recommended as a first line tool for PID diagnosis. For this reason, the clinician is left with maintaining a high index of suspicion for the diagnosis as he/she evaluates the lower genital tract for inflammation and the pelvic organs for tenderness in women with genital tract symptoms and a risk for sexually transmitted infection. This approach should minimize treating women without PID with antibiotics and optimize the diagnosis in a practical and cost-effective way.
Subject(s)
Pelvic Inflammatory Disease/diagnosis , Anti-Bacterial Agents/therapeutic use , Female , Humans , Pelvic Inflammatory Disease/drug therapy , Sexually Transmitted Diseases/diagnosisABSTRACT
Pelvic inflammatory disease (PID) is one of the most common serious infections of nonpregnant women of reproductive age. Management of PID is directed at containment of infection. Goals of therapy include the resolution of clinical symptoms and signs, the eradication of pathogens from the genital tract and the prevention of sequelae including infertility, ectopic pregnancy and chronic pelvic pain. The choice of an antibiotic regimen used to treat PID relies upon the appreciation of the polymicrobial etiology of this ascending infection including Neisseria gonorrhoeae, Chlamydia trachomatis, Mycoplasma genitalium and other lower genital tract endogenous anaerobic and facultative bacteria, many of which are associated with bacterial vaginosis. Currently available evidence and the CDC treatment recommendations support the use of broad-spectrum antibiotic regimens that adequately cover the above named microorganisms. The outpatient treatment of mild-to-moderate PID should include tolerated antibiotic regimens consisting of an extended-spectrum cephalosporin in conjunction with either azithromycin or doxycycline. Clinically severe PID should prompt hospitalization and imaging to rule out a tubo-ovarian abscess. Parenteral broad-spectrum antibiotic therapy with activity against a polymicrobial flora, particularly Gram-negative aerobes and anaerobes, should be implemented.